Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abivax (ABVX.FP)

Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abivax 7-11 boulevard Haussmann Paris 75009 FRA

P: +33 153830963

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Key Statistics

Overview:

Market Capitalization, $K 8,709,592
Shares Outstanding, K 77,903
Annual Sales, $ 0 K
Annual Net Income, $ -176,242 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -153,358 K
% of Institutional Shareholders 2.27%

Growth:

1-Year Return 1,534.56%
3-Year Return 1,450.39%
5-Year Return 249.65%
5-Year Revenue Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.76 on 09/08/25
Next Earnings Date N/A
Earnings Per Share ttm -3.09
Dividend Payout Ratio 0.00%

ABVX.FP Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.41%
Return-on-Assets % -45.01%
Profit Margin % 0.00%
Debt/Equity 1.32
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.62
Interest Coverage -13.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar